Oramed Pharmaceuticals buy melinda
Summary
This prediction ended on 03.09.18 with a price of €4.46. Massive losses of -31.63% were the result for the BUY prediction by melinda. melinda has 50% into this predictionOramed is a pharmaceutical company that focuses on the development of innovative oral delivery solutions for drugs that are traditionally administered through injection. The company is primarily dedicated to the development of an oral insulin capsule that can potentially revolutionize the treatment of diabetes. Their flagship product, ORMD-0801, is currently in Phase III clinical trials in the United States and has received Fast Track designation from the FDA. Oramed is a publicly traded company listed on the Nasdaq under the ticker symbol ORMP.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Oramed Pharmaceuticals | 2.244% | 2.244% | -13.489% | -76.331% |
iShares Core DAX® | -0.922% | -1.078% | 12.165% | 16.796% |
iShares Nasdaq 100 | 0.371% | -0.556% | 38.622% | 49.370% |
iShares Nikkei 225® | 2.224% | -2.825% | 19.015% | 4.643% |
iShares S&P 500 | -0.026% | -0.788% | 28.485% | 42.479% |
According to melinda what are the pros and cons of Oramed Pharmaceuticals for the foreseeable future?
Pros
Cons
Comments by melinda for this prediction
In the thread Oramed Pharmaceuticals diskutieren
Biotechnologie und Medizintechnik SecteurRecherche Agenda 05/04 Ergebnisse Veröffentlichung
Oramed Pharmaceuticals, Inc. engagiert bei der Bereitstellung von oralen Verabreichungslösungen für durch Injektion verabreichte Arzneimittel.
Es konzentriert sich in der Forschung und Entwicklung von pharmazeutischen Lösungen, einschließlich einer orale Insulinkapsel zur Verwendung bei der Behandlung von Menschen mit Diabetes, und die Verwendung von einnehmbaren Kapseln oder Pillen zur oralen Abgabe andere Polypeptide.
Das Unternehmen wurde von Nadav Kidron und Miriam Kidron 12. April 2002 gegründet und ist in Jerusalem, Israel ansässig.
Anzahl der Mitarbeiter: 14 Personen.
Stopped prediction by melinda for Oramed Pharmaceuticals
Oramed Pharmaceuticals
29.12.21
29.12.22
30.12.22
Oramed Pharmaceuticals
30.10.19
04.11.21
05.11.21
Oramed Pharmaceuticals
29.03.19
30.10.19
30.10.19